Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study(vol 22, 498, 2022)

被引：0
|
作者：
Rayer, Cassandra [1 ]
Nachury, Maria [2 ]
Bourreille, Arnaud [3 ]
Roblin, Xavier [4 ]
Peyrin-Biroulet, Laurent [5 ]
Viennot, Stephanie [6 ]
Flamant, Mathurin [7 ]
Laharie, David [8 ]
Caron, Benedicte [5 ]
Dewitte, Marie [1 ]
Siproudhis, Laurent [9 ]
Fumery, Mathurin [10 ]
Bouguen, Guillaume [9 ,11 ]
机构：
[1] Univ Rennes, CHU Rennes, F-35000 Rennes, France
[2] Univ Lille, CHU Lille, Lille, France
[3] CHU Nantes, Nantes, France
[4] CHU St Etienne, St Etienne, France
[5] Nancy Univ Hosp, Dept Gastroenterol, Inserm U954 Deparment Hepatogastroenterol, Vandoeuvre Les Nancy, France
[6] CHU Caen, Caen, France
[7] Clin Jules Vernes, Nantes, France
[8] Univ Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol & Oncol Digest, CHU Bordeaux, F-33000 Bordeaux, France
[9] Univ Rennes, Inst NUMECAN Nutrit Metab & Canc, CHU Rennes, INSERM,CIC 1414, F-35000 Rennes, France
[10] Univ Picardie, Serv Hepatogastroenterol & Oncol Digest, CHU Amiens & PeriTox, UMR I0 I, Amiens, France
[11] Serv Malad Appareil Digest, 2 Rue Henri Le Guillou, F-35033 Rennes, France
来源：
BMC GASTROENTEROLOGY | 2023年 / 23卷 / 01期
关键词：
D O I：
10.1186/s12876-022-02636-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth?
    Liu, Kecheng
    Cai, Fuqing
    Huang, Jiean
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (07) : 1253 - 1254
  • [32] Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
    D'Amico, Ferdinando
    Pugliese, Nicola
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 347 - 353
  • [33] Ustekinumab Efficacy and Safety in Crohn's Disease Patients Refractory to Conventional and Anti-TNF Therapy: A Multicenter Retrospective Experience
    Wils, Pauline
    Bouhnik, Yoram
    Flourie, Bernard
    Brixi, Hedia
    Cosnes, Jacques
    Allez, Matthieu
    Bernard, Duclos
    Michetti, Pierre F.
    Grimaud, Jean-charles
    Bommelaer, Gilles
    Amiot, Aurelien
    Fumery, Mathurin
    Jerome, Filippi
    Abitbol, Vered
    Coffin, Benoit
    Simon, Marion
    Laharie, David
    Pariente, Benjamin
    GASTROENTEROLOGY, 2015, 148 (04) : S115 - S116
  • [34] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S71 - S72
  • [35] EFFICACY OF INFLIXIMAB AFTER FAILURE OF SUBCUTANEOUS ANTI-TNF AGENT IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER STUDY
    Streichenberger, Aurelie
    Pariente, Benjamin
    Bozon, Anne
    Arab, Nadia
    Amiot, Aurelien
    Vuitton, Lucine
    Tilmant, Marion
    Nachury, Maria
    Altwegg, Romain
    Delasalle, Thibault
    Gagniere, Charlotte
    Boivineau, Gregoire
    Fumery, Mathurin
    Wils, Pauline
    de Chambrun, Guillaume Pineton
    Hebuterne, Xavier
    Pereira, Bruno
    Bommelaer, Gilles
    Buisson, Anthony
    GASTROENTEROLOGY, 2018, 154 (06) : S834 - S834
  • [36] ANTI-TNF EFFICACY AFTER PRIMARY VEDOLIZUMAB FAILURE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Dolinger, Michael
    Rolfes, Priya
    Phan, Becky
    Pan, Stephanie
    Dubinsky, Marla
    GASTROENTEROLOGY, 2020, 158 (03) : S116 - S116
  • [37] Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?
    Campochiaro, C.
    Tomelleri, A.
    Galli, E.
    Cocchiara, E.
    Sartorelli, S.
    Muratore, F.
    Malattia, C.
    Caorsi, R.
    Catanoso, M. G.
    Baldissera, E.
    Ravelli, A.
    Salvarani, C.
    Dagna, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : S129 - S134
  • [38] Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Broglio, Giacomo
    Liu, Eleanor
    Limdi, Jimmy K.
    Selinger, Christian
    Fiske, Joseph
    Razanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [39] Is treatment with a third anti-TNF agent a safe and effective option in patients with Crohn's disease?
    Franks I.
    Nature Reviews Gastroenterology & Hepatology, 2010, 7 (2) : 70 - 70
  • [40] COMPARISON OF SHORT AND LONG-TERM EFFICACY BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN PATIENTS WITH CROHN'S DISEASE REFRACTORY TO ANTI-TNF THERAPY
    Manlay, Luc
    Boschetti, Gilles
    Pereira, Bruno
    Buisson, Anthony
    Nancey, Stephane
    GASTROENTEROLOGY, 2021, 160 (06) : S6 - S6
12345